- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: Free Medical School Tuition; NJ Reinsurance Program; Downplaying Addiction With Opioids
Every single future medical student who will study at the New York University School of Medicine, in perpetuity, will have their tuition costs fully covered; HHS has approved New Jersey’s waiver request to create a reinsurance program that would help lower insurance premiums for everyone in the state; an analysis highlights how marketing documents from the mid-1990s downplayed addiction to opioids.
NYU to Give All of Its Medical Students Free Tuition
Every single future medical student who will study at the New York University (NYU) School of Medicine, in perpetuity, will have their tuition costs fully covered. The New York Times reported that the school cited the “overwhelming” debt medical school graduates face, which causes students to seek careers in higher-paying specialties. The hope is that if students have their medical tuition paid for, it can help alleviate the physician shortage. NYU has currently raised more than $450 million of the $600 million it said it will need to finance the tuition plan.
New Jersey Latest State to Receive Approval for Reinsurance Program
HHS has approved New Jersey’s waiver request to create a reinsurance program that would help lower insurance premiums for everyone in the state. The waiver allows the state to reimburse insurers for covering high-cost patients, according to the approval. Other states have implemented reinsurance programs with great success, resulting in far lower premium increases than what other states have reported. New Jersey’s Department of Banking and Insurance expects that the reinsurance program will reduce premium rates by approximately 15% compared with what they would be without the program.
How Addiction to Opioids Was Downplayed
A new analysis from Kaiser Health News outlined how Purdue Pharma’s marketing documents for OxyContin in the mid-1990s downplayed addiction. The documents may be a “smoking gun,” according to one expert, in the thousands of pending lawsuits that allege drug makers engaged in deceptive marketing that fueled the current opioid epidemic. Meanwhile, President Donald Trump wants the federal government to get involved. He is asking Attorney General Jeff Sessions to file lawsuits against some companies that supply and manufacture the powerful painkillers.
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More
